Mamizu Hikaru, Kohda Hiroki, Tomita Yuusuke, Hatakeyama Takuma, Mamizu Maiko, Ishikawa Daisuke, Kawakami Hidenori, Furukawa Toshiki, Ishida Takashi, Sakai Tsuyoshi
Department of Internal Medicine, Niigata Prefectural Central Hospital, Japan.
Department of Diagnostic Pathology, Niigata Prefectural Central Hospital, Japan.
Intern Med. 2024 Oct 1;63(19):2661-2666. doi: 10.2169/internalmedicine.3141-23. Epub 2024 Feb 26.
Amiodarone, a prominent antiarrhythmic drug, may cause lung injury. We herein report the case of an 87-year-old man who had been taking amiodarone for 5 years and was subsequently referred due to respiratory failure. Chest computed tomography revealed multiple consolidations with air bronchograms in both lungs. Despite administering steroid pulse therapy, his respiratory failure worsened, and he died 3 days later. Autopsy revealed hyaline membrane formation and organic formation with fibrin deposition. Drug-induced lung injury caused by amiodarone was confirmed by autopsy. Caution is therefore required when fibrin deposition in the alveolar spaces is observed in such cases, which are prone to suffer a rapid deterioration.
胺碘酮是一种著名的抗心律失常药物,可能会导致肺损伤。我们在此报告一例87岁男性病例,该患者服用胺碘酮5年,随后因呼吸衰竭前来就诊。胸部计算机断层扫描显示双肺有多处实变并伴有空气支气管征。尽管给予了类固醇冲击治疗,但其呼吸衰竭仍恶化,3天后死亡。尸检显示有透明膜形成以及伴有纤维蛋白沉积的机化形成。尸检证实为由胺碘酮引起的药物性肺损伤。因此,在此类易迅速恶化的病例中,当观察到肺泡腔内有纤维蛋白沉积时,需要谨慎对待。